Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reith

Showing results (161-170 of 233) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|December 30, 2009
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal modelsBalaram Ghosh, Tamara Antonio, Juan Zhen, et al.
Journal of Medicinal Chemistry|May 16, 2003
Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amineRohit B Kolhatkar, Sujit K Ghorai, Clifford George, et al.
Journal of Medicinal Chemistry|November 12, 2015
Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's DiseaseBanibrata Das, Seenuvasan Vedachalam, Dan Luo, et al.
ACS Medicinal Chemistry Letters|January 1, 2013
Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potencySanjib Gogoi, Swati Biswas, Gyan Modi, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
An analysis of the binding of cocaine analogues to the monoamine transporters using tensor decomposition 3-d QSARMichael Appell, William J Dunn, Maarten E A Reith, et al.
American Journal of Physiology. Cell Physiology|July 25, 2003
Fluid pressure in human dermal fibroblast aggregates measured with micropipettesL E B Stuhr, A Reith, S Lepsøe, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transportersManoj Mishra, Rohit Kolhatkar, Juan Zhen, et al.
Bioorganic & Medicinal Chemistry|September 4, 2016
Novel multifunctional dopamine D<sub>2</sub>/D<sub>3</sub> receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation propertiesDan Luo, Horrick Sharma, Deepthi Yedlapudi, et al.
Journal of Medicinal Chemistry|December 5, 2008
Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore modelDennis A Brown, Prashant S Kharkar, Ingrid Parrington, et al.
Oncogene|March 7, 1996
Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertionJ Chen, A Nachabah, C Scherer, et al.
Pageof 24

Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|December 30, 2009
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal modelsBalaram Ghosh, Tamara Antonio, Juan Zhen, et al.
Journal of Medicinal Chemistry|May 16, 2003
Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amineRohit B Kolhatkar, Sujit K Ghorai, Clifford George, et al.
Journal of Medicinal Chemistry|November 12, 2015
Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's DiseaseBanibrata Das, Seenuvasan Vedachalam, Dan Luo, et al.
ACS Medicinal Chemistry Letters|January 1, 2013
Novel bivalent ligands for D2/D3 dopamine receptors: Significant co-operative gain in D2 affinity and potencySanjib Gogoi, Swati Biswas, Gyan Modi, et al.
Bioorganic & Medicinal Chemistry|March 12, 2002
An analysis of the binding of cocaine analogues to the monoamine transporters using tensor decomposition 3-d QSARMichael Appell, William J Dunn, Maarten E A Reith, et al.
American Journal of Physiology. Cell Physiology|July 25, 2003
Fluid pressure in human dermal fibroblast aggregates measured with micropipettesL E B Stuhr, A Reith, S Lepsøe, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transportersManoj Mishra, Rohit Kolhatkar, Juan Zhen, et al.
Bioorganic & Medicinal Chemistry|September 4, 2016
Novel multifunctional dopamine D<sub>2</sub>/D<sub>3</sub> receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation propertiesDan Luo, Horrick Sharma, Deepthi Yedlapudi, et al.
Journal of Medicinal Chemistry|December 5, 2008
Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore modelDennis A Brown, Prashant S Kharkar, Ingrid Parrington, et al.
Oncogene|March 7, 1996
Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertionJ Chen, A Nachabah, C Scherer, et al.
Pageof 24